Kings Royal Biotech Inc. — Form D

Kings Royal Biotech Inc. of BARDWELL, KY, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-30. The offering totals $29.5M, of which $750K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-03-30
• Form: D
• Accession: 0001735847-18-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $29.5M
• Amount sold: $750K
• Remaining: $28.8M
• Investors: 7
• Date of first sale: 2018-03-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-309030

Issuer

• Name: Kings Royal Biotech Inc.
• CIK: 0001735847
• Entity type: Corporation
• Jurisdiction: KENTUCKY
• Incorporated: 2017
• Address: 2350 US HIGHWAY 51 N., BARDWELL, KY, 42023
• Phone: 9726585519

Officers, directors & promoters (2)

More

• CIK 1735847 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search